Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?

J Neuroinflammation. 2018 Oct 16;15(1):289. doi: 10.1186/s12974-018-1324-0.

Abstract

It is a well-known fact that DHEA declines on ageing and that it is linked to ageing-related neurodegeneration, which is characterised by gradual cognitive decline. Although DHEA is also associated with inflammation in the periphery, the link between DHEA and neuroinflammation in this context is less clear. This review drew from different bodies of literature to provide a more comprehensive picture of peripheral vs central endocrine shifts with advanced age-specifically in terms of DHEA. From this, we have formulated the hypothesis that DHEA decline is also linked to neuroinflammation and that increased localised availability of DHEA may have both therapeutic and preventative benefit to limit neurodegeneration. We provide a comprehensive discussion of literature on the potential for extragonadal DHEA synthesis by neuroglial cells and reflect on the feasibility of therapeutic manipulation of localised, central DHEA synthesis.

Keywords: Accelerated ageing; Alzheimer’s; Antioxidant; Extragonadal; Immunosenescence; Neuroprotection; Species-specific; Steroidogenesis; Sulphotransferase; Translocator protein.

Publication types

  • Review

MeSH terms

  • Aging
  • Animals
  • Dehydroepiandrosterone / metabolism*
  • Encephalitis / metabolism*
  • Humans
  • Neurodegenerative Diseases / metabolism*

Substances

  • Dehydroepiandrosterone